MREO - Mereo BioPharma transfers ADS listing from Nasdaq Global Market to Nasdaq Capital Market

2023-05-05 16:20:22 ET

• Mereo BioPharma ( NASDAQ: MREO ) said it had received approval to transfer listing of its ADS from Nasdaq Global Market to Nasdaq Capital Market.
• The transfer was effective at the opening of business on May 3, 2023.
• The Nasdaq Capital Market operates similarly to the Nasdaq Global Market and is a continuous trading market. The approval was granted after the company met the applicable market value of publicly held shares requirement for continued listing and all other applicable requirements for initial listing on the Capital Market, except for the bid price requirement.
• This move is expected to enable Mereo to maintain its listing on Nasdaq while also complying with the exchange's continued listing standards.

For further details see: